🇫🇷 France Country × Condition
parkinson disease Clinical Trials in France
Active clinical trials for parkinson disease with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇫🇷 France
Active Trials in France (5)
NCT06291051
Recruiting
Evaluation of the Safety of Electrical Spinal Cord Stimulation in Parkinson's Patients Presenting With Painful Camptocormia
Enrollment
6 pts
Country
🇫🇷 France
University Hospital, Rouen
View Trial → NCT06008704
Recruiting
Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF)
Enrollment
34 pts
Country
🇫🇷 France
University Hospital, Toulouse
View Trial → NCT06885541
Recruiting
Detection of Internal Tremors by Oscillometry in Parkinson's Patient
Enrollment
60 pts
Country
🇫🇷 France
University Hospital, Toulouse
View Trial → NCT03664609
Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Enrollment
5,000 pts
Country
🇫🇷 France
Boston Scientific Corporation
View Trial → NCT07257861
Recruiting
Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life
Enrollment
80 pts
Country
🇫🇷 France
Centre Hospitalier Régional d'Orléa...
View Trial → Frequently Asked Questions
How many parkinson disease clinical trials are active in France?
There are currently 5 active clinical trials for parkinson disease with sites in France, of which 5 are actively recruiting patients.
How can I join a parkinson disease clinical trial in France?
To join a parkinson disease clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are parkinson disease trials in France?
Active parkinson disease trials in France span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology